Shaily Arora

806 total citations
12 papers, 373 citations indexed

About

Shaily Arora is a scholar working on Oncology, Economics and Econometrics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shaily Arora has authored 12 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Economics and Econometrics and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shaily Arora's work include Cancer Immunotherapy and Biomarkers (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Shaily Arora is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Shaily Arora collaborates with scholars based in United States, Canada and Spain. Shaily Arora's co-authors include Aaron M. Cook, Richard Pazdur, Julia A. Beaver, Rajeshwari Sridhara, Sanjeeve Balasubramaniam, Laleh Amiri‐Kordestani, Shenghui Tang, Sara E. Parli, Thomas Pittman and Justin Davis and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Shaily Arora

11 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shaily Arora United States	8	164	103	53	51	46	12	373
Matthew M. Riggs United States	11	100 0.6×	179 1.7×	38 0.7×	8 0.2×	22 0.5×	24	524
Huiling Liu China	10	100 0.6×	120 1.2×	36 0.7×	27 0.5×	5 0.1×	23	318
Juan Pu China	15	75 0.5×	241 2.3×	62 1.2×	161 3.2×	10 0.2×	35	481
Lusia Sepiashvili Canada	10	79 0.5×	160 1.6×	57 1.1×	39 0.8×	7 0.2×	28	485
D S Alberts United States	11	151 0.9×	223 2.2×	40 0.8×	46 0.9×	20 0.4×	36	576
Xiulan Peng China	11	83 0.5×	92 0.9×	40 0.8×	27 0.5×	14 0.3×	30	296
T Kolben Germany	12	43 0.3×	98 1.0×	96 1.8×	69 1.4×	23 0.5×	36	375
Anette Lykke Petri Denmark	9	52 0.3×	93 0.9×	33 0.6×	51 1.0×	6 0.1×	24	400
Masae Ikeda Japan	12	100 0.6×	104 1.0×	29 0.5×	48 0.9×	8 0.2×	44	828
Cynthia M. Nijenhuis Netherlands	14	202 1.2×	172 1.7×	67 1.3×	26 0.5×	17 0.4×	28	535

Countries citing papers authored by Shaily Arora

Since Specialization

Citations

This map shows the geographic impact of Shaily Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaily Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaily Arora more than expected).

Fields of papers citing papers by Shaily Arora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaily Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaily Arora. The network helps show where Shaily Arora may publish in the future.

Co-authorship network of co-authors of Shaily Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Shaily Arora. A scholar is included among the top collaborators of Shaily Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaily Arora. Shaily Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Bono, Petri, Loïc Verlingue, Maria J. de Miguel, et al.. (2023). 694P Full efficacy analysis of phase I/II trial investigating bexmarilimab, a novel macrophage-guided immunotherapy in refractory solid tumors. Annals of Oncology. 34. S483–S484. 1 indexed citations

Agrawal, Sundeep, Shaily Arora, Laleh Amiri‐Kordestani, et al.. (2022). Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021. JAMA Oncology. 9(2). 266–266. 43 indexed citations

Agrawal, Sundeep, Shaily Arora, Jonathon Vallejo, et al.. (2021). Use of single-arm trials to support malignant hematology and oncology drug and biologic approvals: A 20-year FDA experience.. Journal of Clinical Oncology. 39(15_suppl). e13572–e13572. 7 indexed citations

Reynolds, Kerry L., Shaily Arora, Teilo Schaller, et al.. (2021). Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data. Journal for ImmunoTherapy of Cancer. 9(7). e002896–e002896. 26 indexed citations

Anscher, Mitchell S., Shaily Arora, Chana Weinstock, et al.. (2020). Impact of radiotherapy on risk of adverse events in patients receiving immunotherapy: A U.S. Food and Drug Administration pooled analysis.. Journal of Clinical Oncology. 38(15_suppl). 3018–3018. 3 indexed citations

Arora, Shaily, Sanjeeve Balasubramaniam, Hui Zhang, et al.. (2020). FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer. The Oncologist. 26(1). e164–e172. 127 indexed citations

Arora, Shaily, Sanjeeve Balasubramaniam, Wei Zhang, et al.. (2020). FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis. Clinical Cancer Research. 26(19). 5062–5067. 63 indexed citations

Spillman, Dianne, Shaily Arora, Rajesh Venugopal, et al.. (2020). FDA’s Oncology Center for Excellence Pilots Project Orbis: A framework for concurrent submission and review of oncology products among international partners.. Journal of Clinical Oncology. 38(15_suppl). e14125–e14125.

Barbour, Sally, et al.. (2015). 1529 Low risk of drug interactions when rolapitant is coadministered with CYP2D6 or BCRP substrates: Integrated safety results. European Journal of Cancer. 51. S214–S214. 2 indexed citations

10.

May, Casey C., Shaily Arora, Sara E. Parli, et al.. (2015). Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage. Neurocritical Care. 23(3). 374–379. 47 indexed citations

11.

Cook, Aaron M., Shaily Arora, Justin Davis, & Thomas Pittman. (2013). Augmented Renal Clearance of Vancomycin and Levetiracetam in a Traumatic Brain Injury Patient. Neurocritical Care. 19(2). 210–214. 30 indexed citations

12.

Kamerzell, Tim J., et al.. (2010). The Relative Rate of Immunoglobulin Gamma 1 Fragmentation. Journal of Pharmaceutical Sciences. 100(4). 1341–1349. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact